National Biomanufacturing Centre
In early 2006, the £34million National Biomanufacturing Centre was opened at Estuary Commerce Park in Speke.
The building is a state of the art facility where new medicines, vaccines and insecticides are developed and clinically tested. Its aim is to support the UK biotechnology industry, and to promote the North West as a leading edge centre in this field, providing the expertise and facilities at all stages of the production of biopharmaceutical products on behalf of existing and new biotechnology companies.
In recent years, Merseyside has been emerging as a European bio cluster hotspot. The life sciences industry sector employs over 5,000 people in the region, with a further 2,000 employed in the science base in the region's universities, hospitals, and research institutes.
Speke Halewood has become the largest single concentration of commercial companies supplying in market biologic products in Europe. Companies now based here include Eli Lily, Novartis (formerly Chiron Vaccines) and Medimmune who collectively employ 2,000 people
Map showing project location
View interactive map